SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in ...

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in ...

Industrial manufacturing stands apart because of complex supply chains, innovation cycles, regulatory demands, and sustainability goals. It includes process and discrete industries, which differ in ...

(RTTNews) - Tuesday, Gilead Sciences, Inc. (GILD) announced that its subsidiary Kite Pharma's Yescarta has received approval from the FDA for a manufacturing process change that will reduce the median ...